It’s encouraging to see repurposed drugs make their way into cancer research. I’ve written myself about how I used several repurposed drugs in my own journey and remission. An important thing patients often miss is that precision matters. The same drug can behave very differently depending on the cancer type, mutations, metabolic profile and treatment phase. That’s why NGS and other types of genomic testing are so necessary these days to become part of routine testing in cancer.